Implications of the Lapse in Federal COVID-19 Funding on Access to COVID-19 Testing, Treatment, and Vaccines March 28, 2022 Issue Brief A current impasse in Congress threatens continued funding for COVID-19 testing, treatment, and vaccines. The lack of additional federal COVID-19 funding has broad implications for access to these services, particularly for the uninsured, and could undermine efforts to ensure equitable access to these resources.
U.S. Global Funding for COVID-19 by Country and Region: An Analysis of USAID Data June 29, 2022 Issue Brief As Congress again considers increased assistance for the global response to COVID-19, we look at how current U.S. global COVID-19 emergency funding is being channeled, particularly to countries and regions.
Dec. 8 Event: Unpacking the Prescription Drug Provisions of the Build Back Better Act December 8, 2021 Event As the Build Back Better Act shifts from the House to the Senate, there’s considerable interest in provisions that would lower the cost of prescription drugs. The House-passed bill would allow the federal government to negotiate prices for some high-cost drugs in Medicare, and set a hard cap on out-of-pocket…
Analysis Compares President Trump and Democratic Nominee Biden on COVID-19 September 11, 2020 News Release Few issues are likely to matter as much to voters in November’s presidential election as President Trump’s response to the COVID-19 pandemic and resulting economic crisis, which have left almost 200,000 Americans dead and prompted job layoffs and furloughs affecting tens of millions of Americans. A new election brief compares…
Comparing Trump and Biden on COVID-19 September 11, 2020 Issue Brief This issue brief compares President Trump and Democratic nominee Joe Biden on their records, actions and proposals related to the COVID-19 pandemic. It includes a general overview of their respective approaches, followed by a detailed side-by-side.
The Coronavirus Aid, Relief, and Economic Security Act: Summary of Key Health Provisions April 9, 2020 Issue Brief This summary of the Coronavirus Aid, Relief, and Economic Security (CARES) Act highlights and summarizes health-related provisions focused on the COVID-19 outbreak in the United States and support for the global response.
U.S. Global Funding for COVID-19 by Country and Region October 23, 2020 Issue Brief This data note examines the status of U.S. global COVID-19 country, regional, and worldwide funding to assess how much has been committed to date and where it has been directed.
The Paycheck Protection Program and Health Care Enhancement Act: Summary of Key Health Provisions May 1, 2020 Issue Brief Provides a summary of health provisions in the fourth major legislative initiative to address COVID-19, the Paycheck Protection Program and Health Care Enhancement Act.
Payments to Medicare Advantage Plans Boosted Medicare Spending by $7 Billion in 2019 August 17, 2021 News Release The federal government spent $321 more per person for beneficiaries enrolled in Medicare Advantage plans than for those in traditional Medicare in 2019, a gap that amounted to $7 billion in additional spending on the increasingly popular private plans that year, finds a new KFF analysis. The Medicare Advantage spending…
Higher and Faster Growing Spending Per Medicare Advantage Enrollee Adds to Medicare’s Solvency and Affordability Challenges August 17, 2021 Issue Brief This analysis finds that Medicare spending for Medicare Advantage enrollees was $321 higher per person in 2019 than if enrollees had instead been coverage by traditional Medicare, leading to an estimated $7 billion in additional spending in 2019. It also examines the implications of expected growth in Medicare Advantage enrollment and payments per enrollee from 2021 to 2029.